Viral inifection Archives - Seleniumfacts.com

HIV infection is associated with a higher risk of tuberculosis and death. Selenium deficiency is associated with an increased risk of HIV infection. Several trials have shown that selenium supplementation of patients with HIV is associated with beneficial outcomes [Muzembo 2022].

HIV symptoms — **HIV = human immunodeficiency virus.**

Muzembo et al conducted a systematic review of six randomized controlled trials of selenium supplementation of HIV-infected patients. They reached the following conclusions [Muzembo 2022]:

Daily supplementation with 200 mcg selenium slowed the loss of CD4 cells in HIV-infected patients.
The length of selenium supplementation and HIV infection studies varied from 9 to 24 months.
The selenium supplements were well tolerated in all six studies.
Further investigation of the effects of daily selenium supplementation of HIV-infected patients is warranted.

Note: CD4 cells are a particular type of white blood cells that help the immune system fight infections. CD4 cells are also known as CD4 lymphocytes and helper T cells [MedlinePlus 2022].

If untreated, the HIV infection will destroy many CD4 cells, and the immune system will not be able to fight off opportunistic infections [MedlinePlus 2022]. read more

Milestones in early selenium research

1817 Swedish chemist Jöns Jakob Berzelius discovers selenium

1957 Biochemist Klaus Schwarz shows that selenium in microscopic amounts has a vital importance for mammalian health

1969 Professor J.T. Rotruck discovers that selenium has a biochemical role as a component of the antioxidant enzyme glutathione peroxidase

1969 Professors R.J. Shamberger and D.V. Frost report a possible protective effect of selenium against cancer in humans

1973 Professor J.T. Rotruck identifies the enzyme glutathione peroxidase as a selenium-dependent protein

1977 Professor G.N. Schrauzer publishes cancer mortality correlation studies showing an inverse correlation between dietary intakes of selenium and cancer mortality in 27 countries

1988 Professor G.Q Yang summarizes the lessons learned about the selenium-related endemic diseases Keshan disease and Kashin-Beck disease and about the importance of adequate daily selenium intakes

1989 Professor G.G. Duthie publishes evidence for a role of selenium in the prevention of cardiovascular disease

1993 Researcher W.J. Blot publishes the results of the Nutrition Intervention Trials in Linxian, China, showing that supplementation with a combination of selenium and other antioxidants reduces the risk of cancer

1994 Professor G.N. Schrauzer publishes evidence that selenium is important in the maintenance and therapy of HIV-infected patients

1996 Professor Larry Clark publishes the results of a randomized controlled trial – the Nutritional Prevention of Cancer study -- that shows selenium's cancer-protective effects on colon cancer, lung cancer, and prostate cancer

1997 Professor G.F. Combs summarizes the evidence for the protective effects of selenium against cancer

1999 Professor J.E. Oldfield publishes his Selenium World Atlas, mapping areas of selenium deficiency around the world

2000 Researcher O.A. Levander publishes evidence showing an anti-viral effect of selenium

2002 Researcher R. Gärtner shows that supplementation with selenium reduces inflammation in patients with autoimmune thyroiditis

2002 Researcher Margaret Rayman presents the arguments for increasing selenium intakes to realize selenium’s antioxidant and anti-viral and anti-inflammatory effects as well as selenium’s enhancement of immune function and reproductive success.

Tag: Viral inifection

HIV Infection and Selenium Supplementation